<DOC>
	<DOCNO>NCT00823693</DOCNO>
	<brief_summary>The purpose study determine whether Bimosiamose Cream safe effective treatment plaque type psoriasis .</brief_summary>
	<brief_title>Safety Efficacy Study Bimosiamose Cream Treat Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Clinical diagnosis plaque type psoriasis PASI score 515 At least 18 year age Written inform consent Active skin infection More 20 % Body Surface Area ( BSA ) affect psoriasis Use certain antipsoriasis medication treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>